Dermatology Billing Challenges
Dermatology practices navigate a billing landscape where the line between cosmetic and medically necessary services directly impacts reimbursement. Payers scrutinize dermatology claims closely, and documentation must clearly establish medical necessity for every procedure billed to insurance. Services deemed cosmetic, such as removal of benign skin tags for aesthetic reasons, will be denied unless the documentation supports a functional or medical indication.
Biopsy and Lesion Destruction Coding
Skin biopsy codes (11102 for tangential biopsy, 11104 for punch biopsy, 11106 for incisional biopsy) each have add-on codes (11103, 11105, 11107) for additional lesions. The first biopsy uses the primary code, and each subsequent biopsy of the same type uses the add-on. When different biopsy techniques are performed in the same session, report the highest-value technique as the primary code.
Destruction of premalignant lesions (17000 for the first lesion, 17003 for the second through fourteenth, 17004 for fifteen or more) follows a tiered structure. Destruction of benign lesions (17110 for up to fourteen, 17111 for fifteen or more) uses a different counting method. Mixing premalignant and benign destruction codes in the same encounter requires clear documentation distinguishing each lesion type and location.
Mohs Surgery and Phototherapy
Mohs micrographic surgery (17311 for the first stage on the head, neck, hands, feet, or genitalia; 17313 for trunk or extremities) is one of the highest-reimbursed dermatology services. Each stage and tissue block must be documented separately, including the mapping, excision, tissue preparation, and microscopic examination performed by the Mohs surgeon. Codes 17312 and 17314 cover additional stages. Payers frequently audit Mohs claims, so operative reports must detail the defect size, margin assessment, and number of stages required for clearance.
Phototherapy codes (96910 for actinotherapy, 96912 for photochemotherapy, 96922 for total body phototherapy) require documentation of the condition being treated, treatment protocol, and cumulative session count.
Documentation Best Practices
- Photograph lesions before biopsy or destruction and document size, anatomic location, and clinical description in the medical record.
- When performing a biopsy at one site and excision at another, use modifier 59 to distinguish the services and avoid bundling denials.
- Specify the medical indication for every cosmetic-adjacent service. Payers deny phototherapy for conditions like vitiligo unless the documentation demonstrates functional impairment or psychological impact.
- Prior authorization for biologic medications (dupilumab, secukinumab) requires documented failure of first-line therapies. Maintain step-therapy records in the chart.